CD86 and neoplasm: Overall, the transfer of immune stimulatory or regulatory molecules—CD80, CD86, OX40L, HLA-G, and PD-L1—via trogocytosis significantly inhibits anti-tumor immunity and contributes to the development of the immune-suppressive tumor microenvironment.